J Kevin Baird
J Kevin Baird
Professor of Malariology, University of Oxford
No verified email
Cited by
Cited by
Acquired immunity to malaria
DL Doolan, C Dobaņo, JK Baird
Clinical microbiology reviews 22 (1), 13-36, 2009
Global technical strategy for malaria 2016-2030
World Health Organization
World Health Organization, 2015
Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite
I Mueller, MR Galinski, JK Baird, JM Carlton, DK Kochar, PL Alonso, ...
The Lancet infectious diseases 9 (9), 555-566, 2009
A Long Neglected World Malaria Map: Plasmodium vivax Endemicity in 2010
PW Gething, IRF Elyazar, CL Moyes, DL Smith, KE Battle, CA Guerra, ...
Public Library of Science 6 (9), e1814, 2012
The International Limits and Population at Risk of Plasmodium vivax Transmission in 2009
CA Guerra, RE Howes, AP Patil, PW Gething, TP Van Boeckel, ...
PLoS neglected tropical diseases 4 (8), e774, 2010
G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map
RE Howes, FB Piel, AP Patil, OA Nyangiri, PW Gething, M Dewi, ...
PLoS medicine 9 (11), e1001339, 2012
Primaquine therapy for malaria
JK Baird, SL Hoffman
Clinical infectious diseases 39 (9), 1336-1345, 2004
Effectiveness of antimalarial drugs
JK Baird
New England Journal of Medicine 352 (15), 1565-1577, 2005
Global epidemiology of Plasmodium vivax
RE Howes, KE Battle, KN Mendis, DL Smith, RE Cibulskis, JK Baird, ...
The American journal of tropical medicine and hygiene 95 (6 Suppl), 15, 2016
Evidence and implications of mortality associated with acute Plasmodium vivax malaria
JK Baird
Clinical microbiology reviews 26 (1), 36-57, 2013
Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I
DR Hill, JK Baird, ME Parise, LS Lewis, ET Ryan, AJ Magill
Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis
RN Price, L Von Seidlein, N Valecha, F Nosten, JK Baird, NJ White
The Lancet infectious diseases 14 (10), 982-991, 2014
Chloroquine Resistance in Plasmodium vivax
JK Baird
Antimicrobial agents and chemotherapy 48 (11), 4075-4083, 2004
Host age as a determinant of naturally acquired immunity to Plasmodium falciparum
JK Baird
Parasitology today 11 (3), 105-111, 1995
Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000–17: a spatial and temporal modelling study
KE Battle, TCD Lucas, M Nguyen, RE Howes, AK Nandi, KA Twohig, ...
The Lancet 394 (10195), 332-343, 2019
Resistance to Therapies for Infection by Plasmodium vivax
JK Baird
Clinical microbiology reviews 22 (3), 508-534, 2009
Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination
TNC Wells, JN Burrows, JK Baird
Trends in parasitology 26 (3), 145-151, 2010
Neglect of Plasmodium vivax malaria
JK Baird
Trends in parasitology 23 (11), 533-539, 2007
Geographical variation in Plasmodium vivax relapse
KE Battle, MS Karhunen, S Bhatt, PW Gething, RE Howes, N Golding, ...
Malaria journal 13 (1), 1-16, 2014
Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia.
JK Baird, H Basri, MJ Bangs, B Subianto, LC Patchen, SL Hoffman
The American journal of tropical medicine and hygiene 44 (5), 547-552, 1991
The system can't perform the operation now. Try again later.
Articles 1–20